<SEC-DOCUMENT>0001437749-22-009537-index.html : 20220422
<SEC-HEADER>0001437749-22-009537.hdr.sgml : 20220422
<ACCEPTANCE-DATETIME>20220422162041
ACCESSION NUMBER:		0001437749-22-009537
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
REFERENCES 429:			333-194949
REFERENCES 429:			333-204178
REFERENCES 429:			333-210013
REFERENCES 429:			333-216586
REFERENCES 429:			333-227865
REFERENCES 429:			333-230348
REFERENCES 429:			333-233866
REFERENCES 429:			333-237425
REFERENCES 429:			333-254400
FILED AS OF DATE:		20220422
DATE AS OF CHANGE:		20220422
EFFECTIVENESS DATE:		20220422

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aravive, Inc.
		CENTRAL INDEX KEY:			0001513818
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				264106690
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-264445
		FILM NUMBER:		22845832

	BUSINESS ADDRESS:	
		STREET 1:		RIVER OAKS TOWER
		STREET 2:		3730 KIRBY DRIVE, SUITE 1200
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77098
		BUSINESS PHONE:		936-355-1910

	MAIL ADDRESS:	
		STREET 1:		RIVER OAKS TOWER
		STREET 2:		3730 KIRBY DRIVE, SUITE 1200
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77098

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Versartis, Inc.
		DATE OF NAME CHANGE:	20110223
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>arav20220420_s8.htm
<DESCRIPTION>FORM S-8
<TEXT>
Document 1 - file: arav20220420_s8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>ex_361625.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: ex_361625.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>ex_361626.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 3 - file: ex_361626.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>4 <FILENAME>ex_361627.htm <DESCRIPTION>EXHIBIT FILING FEES <TEXT> Document 4 - file: ex_361627.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>ex_361625img001.jpg <TEXT> Document 5 - file: ex_361625img001.jpg
</DOCUMENT> </SEC-DOCUMENT>